CAS: 1931944-80-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Donanemab REF: TM-T77162CAS: 1931944-80-7 | 95% | 214.00 €~2,426.00 € | Tue 07 Jan 25 |
 | Donanemab REF: 3D-CLA1552CAS: 1931944-80-7 | - - - | To inquire | Wed 15 Jan 25 |
Donanemab
CAS:1931944-80-7
Donanemab (LY3002813), a humanized IgG1 antibody, targets N-terminal Aβ for potential early Alzheimer's research.
Purity:
95%
Color and Shape:
Liquid
Ref: TM-T77162
| 1mg | 214.00 € | ||
| 5mg | 552.00 € | ||
| 10mg | 899.00 € | ||
| 25mg | 1,330.00 € | ||
| 50mg | 1,799.00 € | ||
| 100mg | 2,426.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Donanemab
CAS:1931944-80-7
A humanized IgG1 monoclonal antibody targets Aβ N-terminal epitope (p3-42).
Ref: 3D-CLA1552
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
